Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
Kiniksa Pharmaceuticals (KNSA) will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. Eastern Time.
Rhea-AI Summary
Kiniksa Pharmaceuticals (KNSA) will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. Eastern Time.
A live webcast of the presentation will be available via the Investors section of Kiniksa’s website, with a replay accessible on the site approximately 48 hours after the event.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 07 | Conference presentation | Neutral | +0.6% | Management announced participation in a Canaccord Genuity fireside chat. |
| Jul 28 | Second-quarter earnings | Positive | +25.0% | Revenue growth and raised full-year guidance accompanied positive clinical updates. |
| Jul 23 | Earnings date notice | Neutral | -0.3% | The company scheduled its second-quarter financial results conference call. |
| May 29 | Investor conferences | Neutral | +0.1% | Management announced fireside chats at two June healthcare conferences. |
| Apr 28 | First-quarter earnings | Positive | +23.5% | Revenue growth and higher ARCALYST guidance accompanied reported quarterly earnings. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Conference notices produced positive 24-hour reactions of 0.62% and 0.10%, while the July 23 earnings-date notice declined 0.33%; reported earnings releases had larger positive reactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONDON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026 at 8:45 a.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
FAQ
When will Kiniksa Pharmaceuticals (KNSA) present at the Wells Fargo 21st Annual Healthcare Conference?
Kiniksa Pharmaceuticals is scheduled to participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 8:45 a.m. Eastern Time.
How can investors access the Kiniksa (KNSA) presentation at the Wells Fargo healthcare conference?
A live webcast of Kiniksa’s fireside chat will be accessible through the Investors section of the company’s website at www.kiniksa.com.
Will a replay be available for Kiniksa’s Wells Fargo 21st Annual Healthcare Conference presentation?
Yes. A replay of Kiniksa’s conference fireside chat will be available on the company’s website at www.kiniksa.com within approximately 48 hours after the event.
What type of event is Kiniksa (KNSA) hosting at the Wells Fargo healthcare conference?
Kiniksa management will take part in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference, which will be webcast live for investors via the company’s website.